MedsForAll

MedsForAll is creating an ampule autoinjector, resulting in affordable manufacturing, a streamlined regulatory pathway, and the ability to replace expired drug.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, USA
  • Currency USD
  • Founded December 2017
  • Employees 2
  • Incorporation Type C-corp
  • Website medsforallhealth.com

Company Summary

MedsForAll is creating the world’s first ampule based autoinjector. With an estimated $5 to manufacture, our device costs a fraction to build compared to our competition. All our competitors, existing and emerging are manufactured with the drug, requiring replacement of the entire device upon drug expiration, costing the industry $1 billion a year. Our device allows for simple replacement of the drug, eliminating the need for device replacement.

Team

  • Shawn Swanson
    CEO

    Shawn Swanson is the CEO of MedsForAll. He completed his MS MSE in December of 2016, and since then has worked full time with the company. Shawn has been with the team since the beginning, and pursued this as a full time job directly after graduation. As the CEO, he has advanced the prototype, built a network of experienced advisors, and solidified the business plan.

  • Richard Lee
    Co-Founder and CSO

    Richard Lee is the CSO of MedsForAll and specializes in clinical trials, biomedical regulatory affairs, health economics, and global health. As a previous hospital clinician working for CHI Franciscan and community provider with Kaiser Permanente, he provides clinical guidance and strategic decision making.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free